Cardiovascular benefits and safety profile of macrolide maintenance therapy in patients with bronchiectasis
The administration of MMT in patients with bronchiectasis was associated with a significant reduction in the risk of MACE, without any evidence suggesting an increased risk of severe arrhythmia-related adverse events.
Authors
- Christopher Tze‐Wei Tsang (ORCID: https://orcid.org/0000-0003-3394-6604)
- Jiayi Huang (ORCID: https://orcid.org/0000-0003-1783-8195)
- Yap‐Hang Chan (ORCID: https://orcid.org/0000-0001-5384-8468)
- Tommaso Bucci (ORCID: https://orcid.org/0000-0003-2895-6234)
- Anping Cai (ORCID: https://orcid.org/0000-0003-3953-5881)
- Freddy Frost (ORCID: https://orcid.org/0000-0002-3902-6502)
- Q W Ren (ORCID: https://orcid.org/0000-0003-0712-9299)
- Steven Ho Man Lam (ORCID: https://orcid.org/0000-0003-2147-0995)
- Jingnan Zhang (ORCID: https://orcid.org/0000-0002-4865-5212)
- Wenli Gu (ORCID: https://orcid.org/0000-0001-7162-6017)
- Ran Guo (ORCID: https://orcid.org/0000-0002-9424-8140)
- Ching-Yan Zhu
- Gregory Y H Lip
- Kai‐Hang Yiu
- Yik‐Ming Hung
- Dennis Wat
Institutions
- University of Liverpool (GB)
- Hsin Sheng College of Medical Care and Management (TW)
- Liverpool Heart and Chest Hospital NHS Trust (GB)
- Liverpool Heart and Chest Hospital (GB)
- Guangdong Academy of Medical Sciences (CN)
- Liverpool John Moores University (GB)
- Sapienza University of Rome (IT)
- University of Hong Kong (HK)
- Aalborg University (DK)
- Hilti (Liechtenstein) (LI)
Publication Details
- Journal
- European Respiratory Journal
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1183/13993003.01574-2024
- Citations
- 7
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 2.93
Funders
- Hospital Authority
- Sanming Project of Medicine in Shenzhen